Consensus CSX Corporation

Equities

CSX

US1264081035

Real-time Estimate Cboe BZX Other stock markets 01:47:41 2024-04-19 pm EDT			5-day change	1st Jan Change
34.38 ^USD	-0.01%		-2.72%	-0.84%

Apr. 18	UBS Cuts CSX Price Target to $44 From $46, Maintains Buy Rating	MT
Apr. 18	BofA Securities Adjusts CSX Price Target to $39 From $40, Maintains Buy Rating	MT

Evolution of the average Target Price on CSX Corporation

Price target over the last 5 years

History of analyst recommendation changes

a94dd5f97160cdbdeb7c6b8d87f7fee.nmEXLUzux8Wu_59l-iQCmInElUecA4OmVS-DUhIQ8Bo.6hUgR3SohqTZuPo6z1M17PCM03PFUMn_AR21C0MkgH-zBF9vD5eU_MPOrw~5bf8f6e8cacbb3a979f336c3d04eebc4

Analyst Recommendations on CSX Corporation

UBS Cuts CSX Price Target to $44 From $46, Maintains Buy Rating	Apr. 18	MT
BofA Securities Adjusts CSX Price Target to $39 From $40, Maintains Buy Rating	Apr. 18	MT
Raymond James Trims Price Target on CSX to $40 From $41	Apr. 18	MT
Bernstein Trims CSX's Price Target to $35 From $36	Apr. 18	MT
Jefferies Adjusts CSX Price Target to $38 From $40	Apr. 18	MT
RBC Lowers Price Target on CSX to $36 From $37, Keeps Sector Perform Rating	Apr. 18	MT
Bernstein Raises CSX's Price Target to $36 From $35	Apr. 15	MT
Stifel Raises Price Target on CSX to $39 From $38, Maintains Buy Rating	Apr. 12	MT
Jefferies Initiates CSX With Hold Rating, Price Target is $40	Apr. 08	MT
RBC Raises Price Target on CSX to $37 From $34, Keeps Sector Perform Rating	Apr. 01	MT
Susquehanna Raises Price Target on CSX to $44 From $42, Maintains Positive Rating	Mar. 28	MT
ANALYST RECOMMENDATIONS : Abbvie, Microsoft, Tesla, Alphabet, Booking...	Feb. 05
UBS Adjusts CSX Price Target to $40 From $37, Maintains Buy Rating	Jan. 25	MT
BMO Capital Adjusts Price Target on CSX to $38 From $37, Maintains Outperform Rating	Jan. 25	MT
Raymond James Adjusts Price Target on CSX to $38 From $35, Keeps Outperform Rating	Jan. 16	MT
Susquehanna Upgrades CSX to Positive From Neutral, Raises Price Target to $42 From $35	Jan. 08	MT
JPMorgan Trims Price Target on CSX to $39 From $40, Maintains Overweight Rating	Dec. 21	MT
Goldman Sachs Adjusts Price Target on CSX to $38 From $37, Maintains Buy Rating	23-10-20	MT
RBC Trims Price Target on CSX to $34 From $35, Keeps Sector Perform Rating	23-10-20	MT
Rose-colored glasses are back	23-10-11
JPMorgan Upgrades CSX to Overweight From Neutral, Raises Price Target to $40 From $37	23-10-11	MT
ANALYST RECOMMENDATIONS : BAE Systems, Hubspot, Intercontinental, Nasdaq, Netflix...	23-10-11
Goldman Sachs Cuts Price Target on CSX to $37 From $39, Keeps Buy Rating	23-10-10	MT
ANALYST RECOMMENDATIONS : 3M, Amgen, Eli Lilly, PepsiCo, Charles Schwabb...	23-10-09
ANALYST RECOMMENDATIONS : Biogen, Glencore, Home Depot, Meta Platforms, On Semi...	23-10-04

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

34.39 USD

Average target price

39.38 USD

Spread / Average Target

+14.50%

High Price Target

44 USD

Spread / Highest target

+27.94%

Low Price Target

30 USD

Spread / Lowest Target

-12.77%

Consensus detail

Consensus revision (last 18 months)

Analysts covering CSX Corporation

UBS
BofA Securities
Raymond James
Bernstein
Jefferies & Co.
RBC Capital Markets
Stifel Nicolaus
Susquehanna
BMO Capital
JPMorgan Chase
Goldman Sachs
Barclays
Argus
Citigroup
Benchmark Company
Morgan Stanley
TD Cowen
Stephens Inc.
Atlantic Equities
Vertical Research
Cowen
Credit Suisse
Wells Fargo Securities
Deutsche Bank Securities
Loop Capital
Benchmark Capital
Evercore ISI
TD Securities
J.P. Morgan Chase

Ratings for CSX Corporation

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar